In 2023, Emily M. Leproust earned $865.43K in total compensation at Twist Bioscience Corporation, including $685.00K salary and $53.80K bonus. Most recently sold 2,402 shares in Mar 2025. Currently holds stock worth $31.83M. Has donated $7.98M in stock to charitable causes. Led Twist Bioscience Corporation as CEO for 11 years.
Compensation History
Annual executive compensation data for Emily M. Leproust, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$865.43K
Salary
$685.00K
Bonus
$53.80K
Other
$126.64K
Salary
$685.00KBoard Justification
The compensation philosophy is designed to attract and retain key executives, reward performance, and align executive interests with stockholders.
Bonus
$53.80KBoard Justification
The amounts shown in this column for 2023 represent a discretionary bonus equal to 8.7% of the fiscal 2023 target bonus opportunity for Dr. Leproust.
Other Compensation
$126.64KBoard Justification
This includes housing benefits and other compensation.
Restricted Stock
Board Justification
No stock grants were vested in 2023 as the focus is on cash compensation and performance-based bonuses.
Performance Metrics
The performance metrics for 2023 included revenue growth and adjusted gross profit.
Emily M. Leproust
Founder and Ex-CEO of Twist Bioscience Corporation
Education
Ph.D. in Organic Chemistry from University of Houston
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
May 15, 1976 - 49 years ago
CEO of Twist Bioscience Corporation for
11 years 8 months (Mar 2013 - Nov 2024)
Previous Experience
Co-founder and CEO of Twist Bioscience since inception
Holdings
Track Emily M. Leproust's stock holdings and portfolio value over time.
Total Stock Sold
$74.77M
$74.77M
782,194 TWST shares
What if they kept their stock?
If Emily M. Leproust didn't sell their stock, today they would have:
Extra TWST782,194 shares worth $25.26M.
This is -66.21% and $49.51M less than what they got when they sold the stock.
Charitable Transactions
247,150 shares
TWST
Recent Charitable Transactions
1,150 shares
TWST
Dec 27, 2021
Charity
46,000 shares
TWST
Oct 4, 2021
Charity
45,000 shares
TWST
Mar 12, 2021
Charity
$15.60M
TWST at $207.97/share
Feb 9, 2021
Charity
80,000 shares
TWST
Oct 24, 2020
Charity
Insider Trading
Emily M. Leproust's recent stock transactions, purchases, and sales filed with the SEC.
$98.27K
TWST at $40.91/share
Mar 6, 2025
Sale
$123.25K
TWST at $44.18/share
Feb 21, 2025
Sale
$513.26K
TWST at $49.35/share
Feb 3, 2025
Sale
$49.79K
TWST at $45.59/share
Jan 3, 2025
Sale
$148.54K
TWST at $44.90/share
Dec 20, 2024
Sale
$233.58K
TWST at $52.70/share
Dec 6, 2024
Sale
190,700 shares
TWST
Dec 4, 2024
Received
$764.90K
TWST at $48.00/share
Nov 11, 2024
Sale
$1.28M
TWST at $44.61/share
Nov 6, 2024
Sale
$1.28M
TWST at $44.61/share
Nov 6, 2024
Sale
Rivals
Compare Emily M. Leproust with competitor CEOs and industry peers.
Jason Kelly
Founder and CEO of Ginkgo Bioworks
2023 Compensation
Stock
$0.00
Salary
$250.00K
Bonus
$0.00
Other
$12.50K
Total Holdings
$303.74K
John Evans
CEO of Beam Therapeutics
2023 Compensation
Stock
$0.00
Salary
$685.00K
Bonus
$431.55K
Other
$17.68K
Total Holdings
$2.47M
Kimberly J. Popovits
CEO of 10x Genomics, Inc.
2023 Compensation
Stock
$0.00
Salary
$0.00
Bonus
$0.00
Other
$0.00
Total Holdings
$286.13K
Chad Robins
Founder and CEO of Adaptive Biotechnologies
2023 Compensation
Stock
$716.86K
Salary
$663.00K
Bonus
$318.24K
Other
$22.32K
Total Holdings
$118.69M